ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Protests erupt in PoK's Muzaffarabad city against construction of dams by China and Pakistan

Muzaffarabad [PoK], August 25 (ANI): Massive protests and a torch rally was held in Muzaffarabad city of Pakistan occupied Kashmir (PoK) on Monday night to oppose the mega-dams to be constructed by Chinese firms on Neelum-Jhelum River.

ANI Aug 25, 2020 07:01 IST googleads

Massive protests and a torch rally was held in Muzaffarabad city of Pakistan occupied Kashmir (Photo/ANI)

Muzaffarabad [PoK], August 25 (ANI): Massive protests and a torch rally was held in Muzaffarabad city of Pakistan occupied Kashmir (PoK) on Monday night to oppose the mega-dams to be constructed by Chinese firms on Neelum-Jhelum River.
The protesters hailing from ''Darya Bachao, Muzaffarabad Bachao" (Save River, Save Muzaffarabad) Committee'' chanted slogans like "Neelum-Jhelum behne do, humein zinda rehne do" (let the Neelum and Jhelum rivers flow, let us live).
The rally was attended by over a thousand people from the city and other parts of PoK.
Recently, Pakistan and China signed agreements to construct Azad Pattan and Kohala Hydropower Projects in Pakistan Occupied Kashmir.
Azad Pattan Hydel Power Project of 700.7 megawatts of electricity as part of the China-Pakistan Economic Corridor (CPEC) was signed on July 6, 2020. The $1.54 billion projects will be sponsored by the China Gezhouba Group Company (CGGC).
The Kohala Hydroelectric Power Project which will be built on Jhelum River is roughly 7 km upstream of Azad Pattan Bridge in the Sudhanoti District of PoK and 90 km from Islamabad, the capital city of Pakistan.
The project expected to be completed by the year 2026 will be sponsored by China Three Gorges Corporation, International Finance Corporation (IFC) and Silk Road Fund.
What really irks locals is high Chinese presence in the area, massive construction of dams, and river diversions threatening their very existence.
Pakistan and China are jointly plundering the natural resources of PoK and Gilgit Baltistan in the wake of China Pakistan Economic Corridor. The resentment in the occupied territories are high against Pakistan and China. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

China’s expanding system of censorship exposed in Dharamshala

China’s expanding system of censorship exposed in Dharamshala

The event titled "Understanding China's System of Political Repression: Voices of Resistance through Art and Journalism" brought together prominent voices critical of China's information control, as reported by Phayul.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.